
IPD Group (ASX: IPG) posted record FY26 results, with data centre revenue up 27% amid Australia's AI infrastructure boom. Shares reacted well off support and now approach key resistance near $6.00.

Tribune Resources (ASX: TBR) delivered strong 1H FY2026 earnings, supported by higher gold prices and 10,149oz attributable production from its 36.75% EKJV stake. The company retains strong cash generation, fully funded dividends, expanding mine development, and meaningful upside through Star Trek exploration and elevated gold prices.

As Nyrada (ASX: NYR) raises $14 million to advance Xolatryp through Phase IIa trials, the funding extends its development runway and could accelerate clinical milestones, potentially positioning the company for future partnerships with global pharmaceutical companies.

Kaoko Metals has mobilised a second drill rig at its Chalkos Copper-Silver Project in Namibia, testing Donkey Hill and Otniel simultaneously as it accelerates exploration following a recent $23m capital raise.

Global markets were volatile as higher US rates and Saudi pipeline disruption lifted oil costs, strengthened the dollar and pressured risk assets. Australia faces slowing growth, persistent inflation and a cautious ASX, with healthcare resilient while materials, technology and real estate weakened.

4DMedical is scaling its lung-imaging software portfolio, led by CT:VQ, across hospitals and imaging networks. FY26 scan volumes rose 77% to 344,075, while cash reached A$278m; however, the company remains loss-making as it pursues commercial adoption and revenue growth.